Kendall Capital Management Jazz Pharmaceuticals PLC Transaction History

Kendall Capital Management

$316 Million
Q3 2024

A detailed history of Kendall Capital Management transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Kendall Capital Management holds 8,044 shares of JAZZ stock, worth $978,552. This represents 0.28% of its overall portfolio holdings.

Number of Shares

8,044

Previous 8,449 4.79%

Holding current value

$978,552

Previous $901,000 0.55%

% of portfolio

0.28%

Previous 0.31%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$100.57 - $116.37 $40,730 - $47,129	-405 Reduced 4.79%	8,044 $896,000
Q2 2024 Aug 12, 2024	SELL	$103.94 - $118.98 $20,788 - $23,796	-200 Reduced 2.31%	8,449 $901,000
Q1 2024 May 10, 2024	BUY	$115.19 - $132.77 $97,911 - $112,854	850 Added 10.9%	8,649 $1.04 Million
Q4 2023 Jan 26, 2024	BUY	$114.26 - $136.0 $205,096 - $244,120	1,795 Added 29.9%	7,799 $959,000
Q3 2023 Oct 31, 2023	BUY	$122.0 - $145.31 $190,198 - $226,538	1,559 Added 35.07%	6,004 $777,000
Q2 2023 Jul 28, 2023	BUY	$122.5 - $147.16 $71,662 - $86,088	585 Added 15.16%	4,445 $551,000
Q1 2023 May 11, 2023	BUY	$133.98 - $160.47 $84,407 - $101,096	630 Added 19.5%	3,860 $565,000
Q3 2022 Nov 02, 2022	SELL	$126.59 - $161.18 $32,913 - $41,906	-260 Reduced 7.45%	3,230 $431,000
Q2 2022 Jul 29, 2022	SELL	$141.59 - $168.66 $284,595 - $339,006	-2,010 Reduced 36.55%	3,490 $544,000
Q1 2022 May 06, 2022	SELL	$129.64 - $160.7 $258,631 - $320,596	-1,995 Reduced 26.62%	5,500 $856,000
Q4 2021 Jan 28, 2022	SELL	$119.87 - $145.67 $133,655 - $162,422	-1,115 Reduced 12.95%	7,495 $955,000
Q3 2021 Nov 05, 2021	BUY	$128.64 - $184.79 $52,742 - $75,763	410 Added 5.0%	8,610 $1.12 Million
Q2 2021 Jul 30, 2021	BUY	$160.2 - $186.42 $69,687 - $81,092	435 Added 5.6%	8,200 $1.46 Million
Q1 2021 May 05, 2021	BUY	$150.19 - $173.5 $73,593 - $85,015	490 Added 6.74%	7,765 $1.28 Million
Q4 2020 Feb 08, 2021	BUY	$140.71 - $165.05 $17,588 - $20,631	125 Added 1.75%	7,275 $1.2 Million
Q3 2020 Oct 22, 2020	BUY	$105.46 - $144.13 $57,475 - $78,550	545 Added 8.25%	7,150 $1.02 Million
Q2 2020 Jul 30, 2020	BUY	$95.68 - $121.88 $104,291 - $132,849	1,090 Added 19.76%	6,605 $729,000
Q1 2020 Apr 27, 2020	SELL	$87.74 - $152.74 $9,212 - $16,037	-105 Reduced 1.87%	5,515 $550,000
Q4 2019 Jan 24, 2020	BUY	$117.65 - $153.73 $87,061 - $113,760	740 Added 15.16%	5,620 $839,000
Q3 2019 Nov 12, 2019	BUY	$125.18 - $143.24 $359,892 - $411,815	2,875 Added 143.39%	4,880 $625,000
Q2 2019 Aug 09, 2019	BUY	$125.55 - $144.48 $251,727 - $289,682	2,005 New	2,005 $286,000

Others Institutions Holding JAZZ

# of Institutions

511

Shares Held

57.8M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.63B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kendall Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Kendall Capital Management with notifications on news.

Account

Kendall Capital Management Jazz Pharmaceuticals PLC Transaction History